Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-14-017517)

Filing Details

Accession Number:: 0001179110-14-017517
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-03 17:36:13
Reporting Period:: 2014-12-02

Filing Date:: 2014-12-03
Accepted Time:: 2014-12-03 17:36:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1005201	Depomed Inc	DEPO	Pharmaceutical Preparations (2834)	943229046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1367754	M Matthew Gosling	C/O Depomed, Inc. 7999 Gateway Boulevard, Suite 300 Newark CA 94560	Senior Vp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-02	8,819	$15.85	32,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares sold for payment of payroll tax withholdings in connection with vesting of restricted stock. The sales reported in this Form 4 were sold pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.